MedTrace Logo

Periodic Continuous Glucose Monitoring in Patients With Type 2 Diabetes

NCT05633628 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2026-04-29

No results posted yet for this study

Summary

The aim of this randomised controlled trial is to investigate the effectiveness of periodic CGM (continuous glucose monitoring) to support a person-centered approach versus self-monitoring of blood glucose (SMBG) in adults with type 2 diabetes on glucose control and patient reported outcomes.

Conditions

Interventions

BEHAVIORAL

Periodic CGM group with data analysis report- Intervention group

The patients are also instructed to continue to perform SMBG by finger prick if they experience symptoms of hypo- or hyperglycemia. During visit 0 (baseline) the patients is also instructed about how they can log in to the National Diabetes Register (NDR) to access their own NDR's recorded data and use the diabetes questionnaire.

Sponsors & Collaborators

  • Swedish Diabetes Foundation

    collaborator UNKNOWN

  • OneTwo Analytics AB

    collaborator UNKNOWN

  • Sophiahemmet

    collaborator UNKNOWN

  • Sophiahemmet University

    lead OTHER

Principal Investigators

  • Unn-Britt Johansson · Sophiahemmet University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05633628 on ClinicalTrials.gov